IGFBP3 and gastric cancer: We have systematically screened the potential targets of HoxD10 by cDNA microarray and identified multiple genes, including insulin-like growth factor binding protein-3 (IGFBP3) that might be responsible for the tumor suppressing effect of HoxD10 in gastric cancer [4].